• SD Biotechnologies withdrew its board resolution to convene an extraordinary shareholders’ meeting previously rescheduled for Oct. 15, 2026.
• The meeting had been set to vote on articles amendments and a 5-for-1 par value stock consolidation from KRW 200 to KRW 1,000.
• The withdrawal followed a KOSDAQ delisting decision dated Oct. 6, 2026; the company filed for an injunction to suspend its effect.
• Management cited uncertainty over trading resumption timing, complicating fractional-share cash settlement and potentially affecting shareholder rights.
• Any decision to reconvene will be disclosed separately depending on court outcomes and subsequent procedures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SD Biotechnologies Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261007000484), on October 07, 2026, and is solely responsible for the information contained therein.